{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:35:46Z","timestamp":1793205346058,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.det.2017.11.005","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T08:31:19Z","timestamp":1511944279000},"page":"103-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Psychosocial Burden and Other Impacts of Rosacea on Patients\u2019 Quality of Life"],"prefix":"10.1016","volume":"36","author":[{"given":"Elias","family":"Oussedik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bourcier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.det.2017.11.005_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","article-title":"Rosacea: I. Etiology, pathogenesis, and subtype classification","volume":"51","author":"Crawford","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2017.11.005_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2009.04.024","article-title":"Papulopustular rosacea: prevalence and relationship to photodamage","volume":"63","author":"McAleer","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2017.11.005_bib3","first-page":"80","article-title":"Epidemiological studies of the influence of sunlight on the skin","volume":"6","author":"Berg","year":"1989","journal-title":"Photodermatol"},{"issue":"2","key":"10.1016\/j.det.2017.11.005_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1468-3083.2010.03751.x","article-title":"Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group","volume":"25","author":"Elewski","year":"2011","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2017.11.005_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/jdv.13556","article-title":"Prevalence of rosacea in the general population of Germany and Russia - The RISE study","volume":"30","author":"Tan","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"31","key":"10.1016\/j.det.2017.11.005_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7748\/ns.30.31.52.s46","article-title":"Rosacea: clinical features and treatment","volume":"30","author":"Lavers","year":"2016","journal-title":"Nurs Stand"},{"issue":"4","key":"10.1016\/j.det.2017.11.005_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1203475416629118","article-title":"Development and Evaluation of a Rosacea Screening Instrument (Rosascreen)","volume":"20","author":"Tan","year":"2016","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"1571","key":"10.1016\/j.det.2017.11.005_bib8","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1098\/rstb.2010.0404","article-title":"Facial attractiveness: evolutionary based research","volume":"366","author":"Little","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"1561","key":"10.1016\/j.det.2017.11.005_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1098\/rspb.2004.2962","article-title":"Menstrual cycle, pregnancy and oral contraceptive use alter attraction to apparent health in faces","volume":"272","author":"Jones","year":"2005","journal-title":"Proc Biol Sci"},{"issue":"6","key":"10.1016\/j.det.2017.11.005_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1090-5138(01)00083-6","article-title":"Facial symmetry and judgements of apparent health","volume":"22","author":"Jones","year":"2001","journal-title":"Evol Hum Behav"},{"issue":"3","key":"10.1016\/j.det.2017.11.005_bib11","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/j.1751-9004.2008.00109.x","article-title":"Social psychological face perception: why appearance matters","volume":"2","author":"Zebrowitz","year":"2008","journal-title":"Soc Personal Psychol Compass"},{"issue":"2","key":"10.1016\/j.det.2017.11.005_bib12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/1469-8986.3820190","article-title":"The effect of expressing anger on cardiovascular reactivity and facial blood flow in Chinese and Caucasians","volume":"38","author":"Drummond","year":"2001","journal-title":"Psychophysiology"},{"issue":"1","key":"10.1016\/j.det.2017.11.005_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/jdv.13748","article-title":"Feelings of stigmatization in patients with rosacea","volume":"31","author":"Halioua","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2017.11.005_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/bjd.12385","article-title":"An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes","volume":"169","author":"Tan","year":"2013","journal-title":"Br J Dermatol"},{"issue":"Suppl 4","key":"10.1016\/j.det.2017.11.005_bib15","first-page":"S4-16-19","article-title":"Psychological aspects of rosacea","volume":"2","author":"Garnis-Jones","year":"1998","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"6","key":"10.1016\/j.det.2017.11.005_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF00422215","article-title":"Critical review of the international assessments of health-related quality of life","volume":"2","author":"Anderson","year":"1993","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.det.2017.11.005_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","article-title":"Rosacea","volume":"72","author":"Two","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2017.11.005_bib18","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.4081\/dr.2016.6387","article-title":"Rosacea: a clinical review","volume":"8","author":"Mikkelsen","year":"2016","journal-title":"Dermatol Reports"},{"key":"10.1016\/j.det.2017.11.005_bib19","unstructured":"National Rosacea Society. Red alert: rosacea awareness month highlights potential increased health risks. Available at: https:\/\/www.rosacea.org\/press\/red-alert-rosacea-awareness-month-highlights-potential-increased-health-risks. Accessed November 24, 2017."},{"key":"10.1016\/j.det.2017.11.005_bib20","unstructured":"Alinia H, Cardwell LA, Moradi Tuchayi S, et\u00a0al. Symptoms of depression are common in patients with rosacea: PHQ-9 in a diverse rosacea population."},{"issue":"2","key":"10.1016\/j.det.2017.11.005_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13555-015-0077-2","article-title":"Perceptions on the psychological impact of facial erythema associated with rosacea: results of international survey","volume":"5","author":"Dirschka","year":"2015","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"10.1016\/j.det.2017.11.005_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13555-016-0106-9","article-title":"Erythema of rosacea impairs health-related quality of life: results of a meta-analysis","volume":"6","author":"Bewley","year":"2016","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"10.1016\/j.det.2017.11.005_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaad.2007.01.048","article-title":"A\u00a0pilot quality-of-life instrument for acne rosacea","volume":"57","author":"Nicholson","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2017.11.005_bib24","first-page":"348","article-title":"Burden of disease: the psychosocial impact of rosacea on a patient\u2019s quality of life","volume":"6","author":"Huynh","year":"2013","journal-title":"Am Health Drug Benefits"},{"issue":"6","key":"10.1016\/j.det.2017.11.005_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2310\/7750.2010.09053","article-title":"Skin disease and stigma in emerging adulthood: impact on healthy development","volume":"14","author":"Roosta","year":"2010","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"3","key":"10.1016\/j.det.2017.11.005_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2013a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"issue":"4","key":"10.1016\/j.det.2017.11.005_bib27","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/archderm.1938.01480100103009","article-title":"Stigmatization","volume":"37","author":"Klauder","year":"1938","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2017.11.005_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0190-9622(89)70007-4","article-title":"Feelings of stigmatization in patients with psoriasis","volume":"20","author":"Ginsburg","year":"1989","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2017.11.005_bib29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.psych.56.091103.070137","article-title":"The social psychology of stigma","volume":"56","author":"Major","year":"2005","journal-title":"Annu Rev Psychol"},{"issue":"5","key":"10.1016\/j.det.2017.11.005_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1468-3083.2009.03472.x","article-title":"Risk factors associated with rosacea","volume":"24","author":"Abram","year":"2010","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2017.11.005_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1468-3083.2005.01216.x","article-title":"Rosacea and its management: an overview","volume":"19","author":"Gupta","year":"2005","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.det.2017.11.005_bib32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000082564","article-title":"Rosacea: an update","volume":"210","author":"Buechner","year":"2005","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.det.2017.11.005_bib33","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1365-2133.2002.04899.x","article-title":"Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients","volume":"147","author":"Vardy","year":"2002","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2017.11.005_bib34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1080\/13548506.2013.841968","article-title":"Symptom severity and psychological sequelae in rosacea: results of a survey","volume":"19","author":"B\u00f6hm","year":"2014","journal-title":"Psychol Health Med"},{"issue":"11","key":"10.1016\/j.det.2017.11.005_bib35","first-page":"1402","article-title":"Changes in rosacea comorbidities and treatment utilization over time","volume":"9","author":"Yentzer","year":"2010","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.det.2017.11.005_bib36","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1365-2133.2005.06895.x","article-title":"Comorbidity of rosacea and depression: an analysis of the National Ambulatory Medical Care Survey and National Hospital Ambulatory Care Survey\u2013Outpatient Department data collected by the U.S. National Center for Health Statistics from 1995 to 2002","volume":"153","author":"Gupta","year":"2005","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2017.11.005_bib37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jaad.2015.04.028","article-title":"Cardiovascular comorbidities in patients with rosacea: a nationwide case-control study from Taiwan","volume":"73","author":"Hua","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2017.11.005_bib38","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2015.07.009","article-title":"Rosacea is associated with chronic systemic diseases in a skin severity dependent manner: results of a case-control study","volume":"73","author":"Rainer","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2017.11.005_bib39","first-page":"213","article-title":"Stress and the skin","volume":"145","author":"Reich","year":"2010","journal-title":"G\u00a0Ital Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.det.2017.11.005_bib40","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2133.1939.tb10644.x","article-title":"The pathogenesis of rosacea: a review with special reference to emotional factors","volume":"51","author":"Klaber","year":"1939","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2017.11.005_bib41","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00000441-195610000-00013","article-title":"re-evaluation of the rosacea complex","volume":"232","author":"Beerman","year":"1956","journal-title":"Am J Med Sci"},{"issue":"1","key":"10.1016\/j.det.2017.11.005_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/jidsymp.2011.9","article-title":"Rosacea: the cytokine and chemokine network","volume":"15","author":"Gerber","year":"2011","journal-title":"J\u00a0Investig Dermatol Symp Proc"},{"issue":"4","key":"10.1016\/j.det.2017.11.005_bib43","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2004.03.033","article-title":"Rosacea: II. Therapy","volume":"51","author":"Pelle","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2017.11.005_bib44","first-page":"38","article-title":"Rosacea: a review","volume":"34","author":"Culp","year":"2009","journal-title":"P\u00a0T"},{"issue":"4","key":"10.1016\/j.det.2017.11.005_bib45","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/bjd.12734","article-title":"The association between psychiatric diseases, psychotropic drugs and the risk of incident rosacea","volume":"170","author":"Spoendlin","year":"2014","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2017.11.005_bib46","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J\u00a0Gen Intern Med"},{"issue":"2","key":"10.1016\/j.det.2017.11.005_bib47","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000444082","article-title":"Patients with rosacea have increased risk of depression and anxiety disorders: a Danish Nationwide cohort study","volume":"232","author":"Egeberg","year":"2016","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.det.2017.11.005_bib48","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A\u00a0meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.det.2017.11.005_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2009.09.009","article-title":"Depression and immunity: a role for T cells?","volume":"24","author":"Miller","year":"2010","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1016\/j.det.2017.11.005_bib50","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.pnpbp.2010.06.014","article-title":"Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression","volume":"35","author":"Maes","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.det.2017.11.005_bib51","doi-asserted-by":"crossref","first-page":"76396","DOI":"10.1155\/2007\/76396","article-title":"Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy","volume":"2007","author":"Sutcigil","year":"2007","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"10.1016\/j.det.2017.11.005_bib52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1756-185X.2011.01673.x","article-title":"The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis","volume":"15","author":"Liu","year":"2012","journal-title":"Int J Rheum Dis"},{"issue":"10","key":"10.1016\/j.det.2017.11.005_bib53","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/sj.mp.4001084","article-title":"The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs","volume":"7","author":"Kim","year":"2002","journal-title":"Mol Psychiatry"},{"issue":"11","key":"10.1016\/j.det.2017.11.005_bib54","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1517\/14728222.2012.718331","article-title":"Targeting IL-1 in depression","volume":"16","author":"Maes","year":"2012","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"10.1016\/j.det.2017.11.005_bib55","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaad.2015.02.1121","article-title":"Assessment of rosacea severity: a review of evaluation methods used in clinical trials","volume":"73","author":"Hopkinson","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2017.11.005_bib56","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-4362.2003.01780.x","article-title":"Measuring the severity of rosacea: a review","volume":"42","author":"Gessert","year":"2003","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2017.11.005_bib57","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","article-title":"Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness","volume":"107","author":"Chren","year":"1996","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.det.2017.11.005_bib58","article-title":"Interventions for rosacea","author":"van Zuuren","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.det.2017.11.005_bib59","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/bjd.15122","article-title":"Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel","volume":"176","author":"Tan","year":"2017","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2017.11.005_bib60","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)\u2013a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.det.2017.11.005_bib61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"9","key":"10.1016\/j.det.2017.11.005_bib62","first-page":"385","article-title":"Quality of life in patients with rosacea","volume":"65","author":"Salamon","year":"2008","journal-title":"Przegl Lek"},{"issue":"4","key":"10.1016\/j.det.2017.11.005_bib63","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2133.2006.07669.x","article-title":"Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial","volume":"156","author":"Weissenbacher","year":"2007","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2017.11.005_bib64","first-page":"30","article-title":"The effect of pulsed dye laser on the Dermatology Life Quality Index in erythematotelangiectatic rosacea patients: an assessment","volume":"6","author":"Shim","year":"2013","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"3","key":"10.1016\/j.det.2017.11.005_bib65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/14764170902741311","article-title":"Quality of life and rosacea: pulsed dye laser impact","volume":"11","author":"Menezes","year":"2009","journal-title":"J\u00a0Cosmet Laser Ther"},{"issue":"2","key":"10.1016\/j.det.2017.11.005_bib66","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000330555","article-title":"Quality of health care of rosacea in Germany from the patients perspective: results of the national health care study Rosareal 2009","volume":"223","author":"Langenbruch","year":"2011","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.det.2017.11.005_bib67","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2133.2010.09894.x","article-title":"The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities","volume":"163","author":"Aksoy","year":"2010","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2017.11.005_bib68","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/bjd.13408","article-title":"Superiority of ivermectin 1% cream over metronidazole 0\u00b775% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial","volume":"172","author":"Taieb","year":"2015","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2017.11.005_bib69","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/bjd.15155","article-title":"DOMINO, doxycycline 40 mg vs. minocycline 100 mg in the treatment of rosacea: a randomized, single-blinded, noninferiority trial, comparing efficacy and safety","volume":"176","author":"van der Linden","year":"2017","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.det.2017.11.005_bib70","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archderm.1997.03890470111018","article-title":"Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases","volume":"133","author":"Chren","year":"1997","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.det.2017.11.005_bib71","doi-asserted-by":"crossref","first-page":"P106","DOI":"10.1016\/j.jaad.2004.10.430","article-title":"RosaQoL versus Skindex-29 in measuring quality of life impact in rosacea patients","volume":"52","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2017.11.005_bib72","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jaad.2009.08.020","article-title":"A\u00a0pilot study in discrepancies in quality of life among three cutaneous types of rosacea","volume":"62","author":"Kini","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2017.11.005_bib73","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/archderm.135.1.79","article-title":"Use of topical products for maintaining remission in rosacea","volume":"135","author":"Wilkin","year":"1999","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.det.2017.11.005_bib74","first-page":"344","article-title":"Effective sunscreen ingredients and cutaneous irritation in patients with rosacea","volume":"61","author":"Nichols","year":"1998","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.det.2017.11.005_bib75","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12325-009-0037-2","article-title":"Efficacy of topical cyclosporine for the treatment of ocular rosacea","volume":"26","author":"Schechter","year":"2009","journal-title":"Adv Ther"},{"issue":"4","key":"10.1016\/j.det.2017.11.005_bib76","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/ijd.12552","article-title":"Clinical and experimental assessment of the effects of a new topical treatment with praziquantel in the management of rosacea","volume":"54","author":"Bribeche","year":"2015","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2017.11.005_bib77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/jdv.12520","article-title":"A\u00a0multicentre, randomized, placebo-controlled trial establishing the treatment effect of TDT 068, a topical formulation containing drug-free ultra-deformable phospholipid vesicles, on the primary features of erythematotelangiectatic rosacea","volume":"29","author":"Luger","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2017.11.005_bib78","first-page":"333","article-title":"A\u00a0randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks","volume":"11","author":"Chang","year":"2012","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"4","key":"10.1016\/j.det.2017.11.005_bib79","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-4632.2011.05353.x","article-title":"Randomized, double-blind trial of 220 mg zinc sulfate twice daily in the treatment of rosacea","volume":"51","author":"Bamford","year":"2012","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2017.11.005_bib80","first-page":"316","article-title":"Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies","volume":"13","author":"Stein","year":"2014","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.det.2017.11.005_bib81","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fpubh.2016.00159","article-title":"Use your words carefully: what is a chronic disease?","volume":"4","author":"Bernell","year":"2016","journal-title":"Front Public Health"},{"key":"10.1016\/j.det.2017.11.005_bib82","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7525-4-35","article-title":"Quality of life in patients with psoriasis","volume":"4","author":"Bhosle","year":"2006","journal-title":"Health Qual Life Outcomes"},{"issue":"11","key":"10.1016\/j.det.2017.11.005_bib83","first-page":"1873","article-title":"Psycho dermatology: the mind and skin connection","volume":"64","author":"Koo","year":"2001","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.det.2017.11.005_bib84","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1590\/abd1806-4841.20175493","article-title":"The need of dermatologists, psychiatrists and psychologists joint care in psychodermatology","volume":"92","author":"Azambuja","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.det.2017.11.005_bib85","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2147\/PRBM.S7072","article-title":"Psychological interventions in the management of common skin conditions","volume":"3","author":"Shenefelt","year":"2010","journal-title":"Psychol Res Behav Manag"},{"key":"10.1016\/j.det.2017.11.005_bib86","unstructured":"Drake L. Stress management can play key role in rosacea control. Newsletter of the National Rosacea Society. Available at: https:\/\/www.rosacea.org\/rr\/2017\/winter\/stress-management-can-play-key-role-rosacea-control. Accessed November 24, 2017."},{"key":"10.1016\/j.det.2017.11.005_bib87","unstructured":"Pascoe D. Forum page Rosacea Support Community. 2014. 2017. Available at: https:\/\/rosacea-support.org\/community\/index.php?mobile=desktop. Accessed July 11, 2017."},{"key":"10.1016\/j.det.2017.11.005_bib88","unstructured":"Diseases and treatments | American Academy of Dermatology. 2017. https:\/\/www.aad.org\/public\/diseases?redirect. Accessed July 11, 2017."},{"key":"10.1016\/j.det.2017.11.005_bib89","unstructured":"CSPA-Home. 2017. Available at: http:\/\/www.canadianskin.ca\/en\/. Published 2017. Accessed July 11, 2017."},{"key":"10.1016\/j.det.2017.11.005_bib90","doi-asserted-by":"crossref","unstructured":"National Rosacea Society. About Us | Rosacea.org. 2017. 2017. https:\/\/www.rosacea.org\/about. Accessed July 6, 2017.","DOI":"10.36290\/der.2017.002"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863517301638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863517301638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T12:40:37Z","timestamp":1660048837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863517301638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0733863517301638"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2017.11.005","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychosocial Burden and Other Impacts of Rosacea on Patients\u2019 Quality of Life","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2017.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}